Open AccessThe first experience of using the biocomposite material "Osteomatrix" in the clinic of bone pathology
Author(s) -
M. V. Lekshivili,
А. В. Балберкин,
M. G. Vasiliev,
А. F. Kolondaev,
A. L. Baranetsky,
Yu. V. Buklemishev
Publication year - 2022
Publication title -
vestnik travmatologii i ortopedii imeni n.n. priorova
Language(s) - English
Resource type - Journals
eISSN - 2658-6738
pISSN - 0869-8678
DOI - 10.17816/vto99996
Subject(s) - biocomposite , medicine , resection , pathology , surgery , materials science , composite material , composite number
At CITO Clinic of bone pathology new biocomposite material Osteomatrix was used in 15 patients (mainly with tumors and tumor-like diseases) for the plasty of post-resection bone defects. Osteomatrix is composed of bone collagen, hydroxyapatite and sulfated glycosaminoglycanes. Osteomatrix is produced at CITO together with Conectbiopharm Ltd. in the form of granules and blocks. Observation in dynamics with roentgenologic control showed good tolerance of Osteomatrix by patients and distinct accelerated bone regeneration in the zone of bone plasty.